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Abstract
Background: In endemic settings unable to support economic growth, inexpensive
anthelminthics, such as albendazole, are the cornerstone for hookworm infection treatment and
control. However, the overall efficacy of albendazole against hookworm may be reduced after
periodic chemotherapy. (Hotez et al., 2004) In addition, there are few studies exploring the role
of nutritional status as a potential host factor influencing drug response and the constituents of
diet has often been overlooked when determining anthelminthic efficacy, despite previous
accounts of nutrient content of a meal or consumed food item affecting drug metabolism.
Evaluating nutritional status as a potential host factor may partly explain the wide variability of
drug efficacy. (Vercruysse et al., 2011)
Methodology: Ghanaian school children that met inclusion criteria were selected from five
communities previously identified as having high prevalence of hookworm infection. After
enrolling 141 eligible school-age children for baseline assessment, those positive for hookworm
infection were treated with single-dose 400 mg albendazole. Nutritional status and dietary data
were assessed to identify modifiable host factors affecting treatment response.
Principal Findings: Our results showed that the efficacy of single-dose oral albendazole for
curing hookworm infection was significantly reduced for children with lower dietary diversity
and protein intake on treatment day. In addition, children with higher dietary diversity scores
within the same reference period were 3.08 times more likely than those with lower scores to
experience the highest egg reduction rates (p-value 0.0430).
Conclusion: The cross-sectional study provides new data on the nutritional status and dietary
patterns of children in the Kintampo North Municipality and elucidates the potential role of
modifiable host factors in affecting response to treatment.
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Introduction
A Brief Historical Context of Hookworm Disease
The effective control of parasitic soil-transmitted helminth infections in humans has seen
equal amounts of success and failure. Public health initiatives and the engines of socioeconomic
development led to the near eradication of hookworm disease in the early 20th century America,
but such achievement has proven to be extremely difficult in developing countries afflicted with
chronic poverty and poor sanitation. (Hotez et al., 2005) As one of the most widespread
neglected tropical diseases in the world, hookworm not only impacts the health of affected
populations, but also plays a negative role in education and rural poverty. (Gillespie, 2001)
Furthermore, moderate to heavy hookworm infection in children results in severe deficits—
anemia, iron deficiency, and retarded physical and cognitive growth.
(Dreyfuss et al., 2000; Hotez et al., 2004; Hotez, 2006)
In 2001, the 54th World Health Assembly declared helminth control as a top priority in
the global health arena. As children and women of reproductive age are at a more heightened
risk for hookworm-related anemia, hookworm has been increasingly targeted by maternal and
child health programs. In addition, ongoing prevention and control efforts include the promotion
of large-scale treatment programs in at-risk settings (e.g., school-based deworming) and the
development of anthelminthic drugs and vaccines. (Brooker et al., 2004)
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Hookworm Disease Biology
Hookworms are nematode endoparasites from the family Ancylostomatidae—with the
species Ancylostoma duodenale and (predominant) Necator americanus causing human infection
after skin exposure to fecally contaminated soil. (Brooker et al., 2004) Primarily affecting
impoverished regions of the tropics and subtropics, the combination of warm, shaded climates
(ideally 20–30 degrees Celsius) and moist soils provide the optimum environment for hookworm
larvae. Although hookworm may enter any part of the human body, the resulting burning rash or
localized “ground itch” is often found on the hands and feet of an infected host—the most
vulnerable sites for parasite entry. (Hotez et al., 2004; Hotez, 2006)

Developmental Processes of the Hookworm Life Cycle
Before entering human hosts, the infective larvae live in fecally contaminated soil where
warm temperatures and moisture provide a safe haven from desiccation (Figure 1). During their
time in an external environment, hookworm eggs hatch into first-stage (L1) rhabditiform larva
and eventually molt twice to transform into the infective larval stage—third-stage larva (L3).
Hookworm infection develops after filariform larva penetrates the skin of a susceptible host.
After entering the host through skin invasion and the production of proteolytic enzymes, the
hookworm larvae continue to grow and migrate toward the lungs and other pulmonary
vasculature. (Gillespie, 2001; Hotez, 2006) After the unknowing host coughs up and swallows
the larvae, they enter the gastrointestinal tract and ultimately mature into adult-stage worms (L4)
in the small intestine. It is here where sexually mature adult worms mechanically attach
themselves to the intestinal wall with their buccal capsules and cutting plates and cause intestinal
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blood loss in the gut. (Gillespie, 2001) The consequences of infection and chronic blood loss
will be discussed later in further detail.
The next life stage of the hookworm involves mating and sexual reproduction—a single
female has the ability to produce between 10,000 and 20,000 eggs per day, which ultimately
leave the body through feces. (Hotez et al., 2004) A hookworm egg is described as “thinshelled, hyaline, and ovoid, measuring approximately 60 x 40 μm”. (Hotez, 2006) After fecal
excretion by the host into the environment, fresh hookworm eggs are then able to take the
necessary step to develop and repeat the parent life cycle. (Hotez et al., 2004)
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Figure 1. Hookworm life cycle
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Hookworm Pathogenesis – The Disease
Moderate to severe hookworm infections are often accompanied by abdominal pain (from
intestinal inflammation), nausea, fatigue, diarrhea, pallor, and heart murmurs. During the pivotal
stage of the hookworm life cycle, the developing worm will mechanically “hook” onto the wall
of the small intestine with its mouthparts and cause host blood loss from feeding on blood and
mucosa (e.g., destruction of mucosal capillaries and secretion of anticoagulant peptides). (Hotez,
2006) Intestinal blood loss from Necator americanus and Ancylostoma duodenale has been
estimated to be as high as 0.03 mL and 0.15 ml per worm per day, respectively. (Hotez et al.,
2004) Some of the most severe consequences of chronic intestinal blood loss include iron
deficiency anemia and hypoalbuminemia.
(Brooker et al., 2004; Gillespie et al., 2001; Hotez et al., 2004)
Because of their increased iron needs, children and pregnant women are especially at risk
for the deleterious effects of hookworm-related anemia. (Hotez, 2006) In childhood, severe
hookworm disease has led to considerable developmental delays in physical and mental growth.
(Hotez, 2006) For example, significant loss of iron and plasma proteins affects the regulation of
enzymatic systems with an iron prosthetic group (e.g., neurotransmitters)—resulting in infectionassociated cognitive and intellectual delays. (Gillespie, 2001) For women of reproductive age
and pregnant mothers, hookworm-associated anemia has been reported as a risk factor for
increased maternal mortality and low birth weight among newborns. (Brooker et al., 2004;
Hotez, 2006)
There is a non-linear association between infection and morbidity—infection is not
always sufficient for hookworm disease and acute symptoms are usually only seen in individuals
harboring large worm burdens. Similar to other intestinal nematode species, hookworm infection
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intensity follows a non-random pattern of worm distribution in humans. Most infected
individuals suffer from light burdens, while a small minority is heavily infected with a large
disproportionate number of worms. (Brooker et al., 2004; Gillespie, 2001) The predisposition
of “wormy individuals” to heavy patterns of infection remains poorly understood.
Although hookworm infection does not follow a normal distribution of infection by age,
young children with low iron stores are most vulnerable to blood loss. Hookworm infection can
occur in children as young as six months and increase with age until reaching a plateau in
adulthood. (Brooker et al., 2004; Gillespie, 2001) As previously mentioned, when children are
continuously infected with hookworm, chronic iron deficiency can lead to delays in physical
fitness and mental development. (Brooker et al., 2004; Hotez et al., 2004)
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Human Immune Responses to Hookworm Infection
Although protective immunological responses have been difficult to describe in both
human and animal models, a consistent observation from infected individuals has been the
distinct T helper type 2-activated production of interleukins (4, 5, 6, 9, and 10), circulation of
eosinophilia, and antibody isotypes (IgG1, IgG4, and IgE). (Brooker et al., 2004) As reported
by Jarrett et al., blood serum levels of IgE are elevated by 100-fold in patients with hookworm
infection. In an experimental human hookworm infection study, antigen specific IgE increased
during primary infection and were significantly boosted following secondary infection. (Wright
and Bickle, 2005) In addition, the subsequent secretion and release of toxic granules and
reactive oxygen intermediates from these immune cells target different stages of the hookworm
parasite with toxic activity. Despite their roles being poorly understood, IgG1 and IgG4 levels
are also increased and upregulated during infection. (Brooker et al., 2004) The final observed
immune response is peaked eosinophil counts during the course of infection. (Loukas and Prociv,
2001; Wright and Bickle, 2005) Following experimental human infection, eosinophilia has been
confirmed to be involved in the inflammatory responses to hookworm L3 in submucosal tissues.
(Wright and Bickle, 2005) Although adult hookworms have been reported to stimulate the
production of secretory IgE, IgG, and even IgM in humans, there is no marked IgA response to
infection. Its absence may be due to the secretion of hookworm IgA-proteases. (Loukas and
Prociv, 2001)
As evidenced by overlapping distributions of infection with other pathogens, hookworms
may exhibit immunosuppressive properties which allow for increased susceptibility to
polyparasitic infections, such as malaria, tuberculosis, and HIV/AIDS. (Brooker et al., 2004;
Hotez, 2006) As an example of adversely influencing host immune response, the hookworm-
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induced activation of eosinophilia may result in the upregulation of CD4+ molecules on host cell
surfaces, thus supporting progression of HIV infection. (Brooker et al., 2004) The influence of
helminthes on susceptibility and progression of bacterial and viral diseases warrants further study.

Present Epidemiology
With an estimated 740 million cases worldwide and an additional 4.5 billion individuals
at risk, hookworm is one of the most common parasitic infections in tropical and subtropical
regions. (Hotez et al., 2004; Keiser and Utzinger, 2008; Saathoff et al., 2005) The life cycle of
the hookworm is closely associated with the rural poverty found in developing countries where
poor sanitation, inadequate housing, and lack of healthcare access allow the parasitic disease to
become stubbornly endemic. (Hotez et al., 2004) Not surprisingly, hookworm is seldom seen in
urban cities, but rather, occurs mostly in sandy coastal regions—perfect living environments for
the survival and development of larvae.

Global Distribution and Burden of Disease
The highest prevalence and intensity of hookworm infection is found in Sub-Saharan
Africa (29%), with China (16%), South and East Asia (16% and 26%, respectively), and the
Central and South Americas (10%) following closely behind (Figure 2). (Brooker et al., 2004;
Hotez, 2006) Although Necator Americanus is the predominant infective species in many parts
of the world, Ancylostoma duodenale infections are also commonly seen in Africa, India, and
China. (Hotez, 2006) Decreases in infections have been observed in Asia and the Americas due
to vast improvements in socioeconomic status and control programs. (Brooker et al., 2004) For
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instance, overall hookworm prevalence in Thailand drastically decreased from 40.6% in 1982 to
11.4% in 2001. (Anantaphruti et al., 2007)
By adding the number of years lost to premature death and years of life lived with a
disability or ill-health, the disability-adjusted life year (DALY) measure offers an estimate of the
overall disease burden in a population. According to the most recent Global Burden of Disease
study, hookworm was responsible for the worldwide loss of 1.8 million DALYs in 2001—with
23% of the total lost in Sub-Saharan Africa alone. However, as hookworm disease may
contribute to iron deficiency anemia (12 million DALYS) in endemic settings, the hookwormattributed DALY is almost certainly underestimated. (Brooker et al., 2004)

Figure 2. The global distribution of hookworm (WHO)
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Disease Occurrence in At-Risk Settings – Ghana
Sub-Saharan Africa has the highest prevalence of hookworm with approximately 200
million infections. (Saathoff et al., 2005) There has been little change in steadfast prevalence
rates across the continent due to serious political, economic, and social challenges. With a
population of over 24 million people, Ghana has seen prevalence rates exceed 50% in certain
parts of the country—from 45% in the Kintampo North District to 87% in rural northern Ghana.
(Humphries et al., 2011; Zeim et al., 2006)

Prevention Strategies and Control Methods
Due to lack of socioeconomic mechanisms and health infrastructures, hookworm control
has been extremely difficult in high transmission areas throughout Sub-Saharan Africa. Instead
of total eradication, control methods for this disease have focused on large-scale chemotherapy
programs and improved sanitation and water services. Although needed for long-term control of
parasitic diseases, sanitation (e.g., access to clean latrine facilities) and behavior change (e.g., use
of footwear) must be complemented with chemotherapeutic measures to effectively interrupt
hookworm transmission in rural communities. (Brooker et al., 2004)

Current Concepts in Treatment – Mass Drug Administration
In hookworm endemic settings unable to support economic growth, inexpensive
benzimidazole anthelminthics are the cornerstone for infection treatment and morbidity control.
(Brooker et al., 2004) Periodic mass drug administration programs are one of the most costeffective health interventions in developing countries and often organized in local schools and
health clinics as part of an integrated national control effort. (Knopp et al., 2010) Deworming
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treatments are based on either a single dose of albendazole or mebendazole. As broad-spectrum
benzimidazole anthelminthics, both albendazole and mebendazole are affordable, effective, and
easy to administer in large communities. (Gillespie, 2001) From a public health perspective,
numerous reviews have confirmed the reduction of hookworm-associated morbidity and
improved health outcomes with regular chemotherapy. (Brooker et al., 2004) For example, a
semi-annual treatment program in Zanzibar resulted in a 55% reduction of severe anemia among
school-age children. (Stoltzfus et al., 1998)

Chemotherapeutic Treatment of Intestinal Hookworms
The range of single-dose anthelminthics available for hookworm treatment, as endorsed
by the World Health Organization, include: albendazole (400 mg), levamisole (2.5 mg/kg),
mebendazole (500 mg), and pyrantel pamoate (10 mg/kg). (Savioli et al., 2004) Anthelminthics
act on metabolic pathways or the nervous system of nematodes. (Coles et al., 1975) With the
aim to cut down worm burden and transmission potential, periodic treatments with
anthelminthics have been shown to drastically reduce chronic morbidity in high risk settings.
(Albonico et al., 2004) Despite enduring levels of hookworm transmission and large numbers of
reinfections, anthelminthics remain integral in control programs against soil-transmitted
helminths due to its low cost and accessibility through community-based programs.
(Gillespie, 2001; Savioli et al., 2004)
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Mebendazole
Most helminth control programs exclusively use benzimidazole treatments due to its
single-dosage form and ease of administration in children. (Albonico, 2003) Although
systematic reviews have shown that albendazole is more effective for curing hookworm infection
than mebendazole, the latter continues to be used for safe treatment of roundworm, pinworm,
whipworm, and other helminth infections in developing countries. (Keiser and Utzinger, 2008;
Miller et al., 1974) For a hookworm-infected individual (regardless of age and weight), a single
dose of mebendazole twice a day for three consecutive days is recommended for clearance.
(Hotez, 2006) Its primary mode of action involves the selective inhibition of microtubule
formation (and subsequent glucose depletion) in worms. The efficacy of mebendazole varies
considerably due to factors such as preexisting diarrhea and gastrointestinal transit time, intensity
of infection, and strain diversity in helminth parasites. (Miller et al., 1974; Munst et al., 1980)

Albendazole
Albendazole is a more potent benzimidazole; even at low dosages, it is rapidly absorbed
from the small intestine resulting in increased concentrations in tissue. (Cook, 1990) In
comparison with other benzimidazole compounds, its better potency may be due to its stronger
bond at the drug-receptor binding site (nematode β-tubulin). (Theorides et al., 1975) As the
drug of choice for treatment against hookworm, it may also be used to treat roundworms,
tapeworms, and pinworms. Although evidence from published literature indicates that
albendazole is satisfactory for the treatment of hookworm, varying levels of efficacy in endemic
settings has also been reported. (Albonico, 2003; Vercruysse et al., 2011) A clinical evaluation
of albendazole will be discussed with more depth in the following section.
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Levamisole
Although levamisole has been used in previous control efforts, it is less effective than
benzimidazoles against human infections from Necator americanus. (Albonico, 2003) However,
it is still used as a veterinary anthelminthic to treat worm infestations in livestock. (Gillespie,
2001) As a synthetic imidazothiazole derivative, its mechanism of action involves nicotinic
agonists at acetylcholine receptors and interference with neuromuscular transmission in
nematodes resulting in worm contractions and paralysis. (Coles et al., 1975)

Pyrantel Pamoate
While chemically different from previous anthelminthic agents, pyrantel pamoate is
efficient against a variety of intestinal parasites. Similar to levamisole, pyrantel pamoate causes
depolarization of acetylcholine receptors and ensuing paralysis of the intestinal helminth. The
affected worms exit the host in the excretion of stool. Although well tolerated in humans,
pyrantel is not often used for periodic therapy due to poor absorption in the gastrointestinal tract.
(Gillespie, 2001)
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A Clinical Evaluation of Albendazole
As an active and equipotent benzimidazole derivative, single-dose albendazole is
inexpensive, safe, and highly effective in treatment of soil-transmitted helminth infections.
Although mebendazole is also safe and well tolerated, albendazole is the preferred treatment
regimen for various mass drug administration programs. (Jongsuksuntigul et al., 1993) In
addition, it provides major advantages over previous anthelminthics due to its unique broad
spectrum of activity for use in at-risk settings, efficacy against immature larval stages, and low
toxicity in the host. (Campbell, 1990; Cook, 1990)
Conducted by Keiser et al., a recent meta-analysis of overall cure rates from the
recommended dosage of albendazole demonstrates its broad anthelminthic efficacy and safety in
humans: hookworm (72%), Ascaris lumbricoides (88%), and Trichuris trichura (28%). In
comparison, treatment of hookworm with mebendazole resulted in 15% cure rate in the same
review. Similar to the general spectrum of activity of the benzimidazole drug family,
albendazole acts against the parasite by disruption of metabolic pathways and energy production.
(Keiser and Utzinger, 2008)

Drug Metabolism and Mechanism of Action
A single dose of 400 mg is recommended for clearance of hookworm infection,
regardless of age and weight of the individual. After albendazole is absorbed from the
gastrointestinal tract, the drug passes through the liver and returns to the rumen and small
intestine by way of the bile duct and blood. The compound and its metabolites are distributed
throughout the body and extensive metabolic processes begin expulsion of the intestinal parasite.
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(Campbell, 1990) Albendazole has been reported to have moderate to high drug potency against
both arrested and developing larval stages and adult worms in the gut.
(Campbell, 1990; Horton, 2000)
Albendazole negatively selects against helminth tubulin in mammalian hosts—previous
studies have confirmed nematode β-tubulin to be the site of benzimidazole drug action. (Lacey,
1990) The selective attachment of albendazole to tubulin receptors within the parasite inhibits
formation of cytoplasmic microtubules—ultimately disrupting cell division. Other noted
mechanistic effects of albendazole are the reduction of glucose uptake and depletion of
adenosine triphosphate storage in the parasite. (McKellar and Scott, 1990; Lacey, 1990)

Literature Review of Effects of Nutritional Status and Host-Related Factors on
Treatment Response
Although albendazole has been to shown to cure infection and reduce worm burden with
higher efficacy than mebendazole, both benzimidazole carbamates have demonstrated low cure
rates and varied efficacy against hookworm. (Anantaphruti et al., 2007; Hotez et al., 2005;
Soukhathammavong et al., 2012; Steinmann et al., 2011; Vercruysse et al., 2011) In parts of
Africa where hookworm infection by Necator americanus is prevalent, varying cure rates have
been reported across different regions after treatment with single-dose albendazole.
(Anantaphruti et al., 2007)
As specific host factors may affect hookworm disease transmission, they may also play
an influential role in the efficacy of anthelminthics. A number of modifiable host factors could
be responsible for variations in drug efficacy, particularly nutritional state and availability of
nutrients during treatment. Surprisingly, there are few descriptions of the influence of nutritional
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status on drug response, especially since malnutrition may negatively alter the fate of the
anthelminthic drug as it moves from the site of administration to the site of infection.
(Krishnaswamy, 1978) Similarly, the influence of diet has often been overlooked when
determining anthelminthic efficacy, despite previous accounts of nutrient content of a meal or
consumed food item affecting drug metabolism. (Santos and Boullata, 2005)
Proteins, carbohydrates, fats, and vitamins and minerals are essential for sufficient
nutritional status. However, hookworm disease is often prevalent in areas where individual diets
lack these nutritional components. In a milestone study, Duncombe et al. demonstrated that
anthelminthic therapy (with mebendazole) was notably less effective in combined iron and
protein deficient rats than in their nutritionally sufficient counterparts. Previous findings also
confirm the authors’ conclusion that iron and protein deficiency may significantly delay normal
worm expulsion in animal models. Anthelminthic treatment was significantly less effective in
iron and protein deficient rats when compared with sufficient animals (p-value < 0.01).
Furthermore, drug efficacy was improved in animals after restoring sufficient nutrition and
protein. (Bolin et al., 1977) Preliminary extrapolation of animal studies to humans suggest that
it may be fruitful to explore the effects of iron and protein deficiency in potentiating helminth
infections and altering response to benzimidazole treatment.
The anti-parasitic activity of albendazole is dependent on drug affinity for parasite βtubulin and increased drug concentration at the localized site of tissue infection. (Lacey, 1990)
The oral administration of albendazole introduces several uncertainties related to its absorption,
bioavailability, and transformation in the body. Bioavailability describes the rate and extent of
drug absorption—equally important properties for identifying the response to drug dose.
Bioavailability following orally administered albendazole treatment may vary due to either host-
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related or dosage-form-related factors. However, lower bioavailability during chemotherapeutic
treatment may permit higher concentrations of drug to remain in the gut environment—a
potentially favorable effect for improved worm expulsion. Other host factors include the nature
and timing of meals, age, disease, genetic traits, and gastrointestinal physiology. (Krishnaswamy,
1978)
According to Munst et al., the bioavailability and absorption of mebendazole in the host
subject was significantly enhanced if the drug was given together with a fatty meal.
Concomitant food intake with mebendazole increased plasma concentrations of 17 nmol/L to 134
nmol/L in human subjects. In another albendazole drug study, systemic availability, as measured
by mean plasma concentrations, increased five-fold when taken with a fatty meal (estimated fat
content 40 g) at breakfast time. The previous results strongly conclude that enhanced systemic
availability of benzimidazole may require the drug to be taken with meals, but oral
administration on an empty stomach (fasting) may be more effective for intestinal infections due
to increased intraluminal drug concentrations. (Lange et al., 1988) In a separate study
evaluating different fasting intervals in calves, the availability of albendazole and its metabolites
in gastrointestinal mucosa and fluids were observed to be greater in fasted calves than those who
fed freely. (Sanchez et al., 1997)
In addition to the pH of the intestinal lumen, gastric emptying time, intestinal blood flow,
gut bacteria, digestive diseases (in the gastrointestinal tract), malnutrition, and
immunodeficiency may also play supporting roles in lowered anthelminthic efficacy.
(Krishnawamy, 1978) Other host factors include differences in gastrointestinal transit time
(which is accelerated by diarrhea) and diet which affects the rate of intestinal transit, thus
decreasing the duration of exposure of parasites to albendazole and reducing its drug efficacy.
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(Nagy et al., 2002; Sanchez et al., 1997) In addition, the results of another study by Kohri et al.
suggest that albendazole absorption and bioavailability is influenced by gastric acidity—rabbits
with low gastric pH (around pH 1) experienced a three-fold increase in bioavailability of
albendazole compared to those with relatively greater gastric pH (pH 5 or higher).

Assessment of Treatment Efficacy in Public Health
Comparative studies on the evaluation of albendazole treatment using a standardized
protocol in Africa, Asia, and South America has shown promising, but varying therapeutic
efficacy. (Vercruysse et al., 2011) In another systematic review, albendazole (72% cure rate)
was more effective in clearing hookworm infection than mebendazole and pamoate (15% and
31% cure rate, respectively). (Keiser and Utzinger, 2008) Despite the current therapeutic
advantage of albendazole, variations in drug efficacy in endemic areas shine a spotlight on
potential drug resistance. Equally unsettling, in rural areas with high transmission potential,
hookworm-positive children often become reinfected within a year after receiving
chemotherapeutic treatment. (Hotez, 2006) Even in regions with lower rates of transmission,
hookworm reinfection has been frequently observed in populations. (Hotez et al., 2004; Hotez,
2006) Because of frequent treatments needed to target reinfections, efficacy of benzimidazole
anthelminthics may diminish with periodic therapy. (Hotez et al., 2004)
After many years of large-scale treatment of livestock and farm animals, the presence of
drug resistance has been frequently reported in different parts of the world. (Albonico et al.,
2004) Livestock populations with high levels of resistance to benzimidazole have arisen in
Africa, South America, and Europe. (Albonico et al., 2003; Albonico et al., 2004) With such
alarming reports and troubling lessons from livestock, there is a rising concern that targeted mass
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treatment with the same albendazole regimen will ultimately result in a selection of worms with
resistant genotypes. (Albonico et al., 2004) More importantly, small-scale studies have detailed
mebendazole and pyrantel drug failure in the treatment of human hookworm infections.
(Albonico et al., 2004; Savioli et al., 2004) However, the threat of emerging resistance should
be approached cautiously and with an open mind—low cure rates in humans may have other
underlying mechanisms and there is not yet any evidence of genetically-transmitted drug
resistance in the field. (Albonico et al., 2004)
A resolution passed by the World Health Organization (2001) called for regular
chemotherapeutic treatments for at least 75 percent of all school-age children at risk for
hookworm. (Hotez et al., 2004; Albonico et al., 2004) Although chemotherapy-based public
health interventions are important control measures, evidence of reduced drug efficacy and
potential for drug resistance requires that improved strategies and methods be implemented to
sustain lasting progress in the worldwide reduction of hookworm disease. (Albonico et al.,
2003) Recommended control approaches, as it relates to the findings of this study, will be
discussed later in greater detail.

Study Purpose and Rationale
In evaluating response to albendazole treatment, it is important to consider a variety of
host-related factors that could affect response—with dietary intake and nutritional status of
individuals being potential factors. Already prevalent in young children across Sub-Saharan
Africa, malnutrition may have the ability of altering drug metabolism and disposition.
According to reports by Mao et al., the capacity and affinity of cytochrome P450 enzymes were
impaired by protein deficiency and calorie malnutrition in rats—diminishing drug metabolism.
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In another animal study, reduced substrate binding was displayed in young rats fed a reduced
protein diet similar in low protein value of diets consumed by children with malnutrition.
(Anthony, 1973) The deleterious effect of malnutrition have also been observed in previous
human studies—poor nutrition was associated with compromised metabolic drug activity in
Sudanese school-age children. Notably, after restoring proper nutrition, reduction of metabolism
was reversed. Many host factors may have contributed to the improved outcome, particularly
sufficient nutritional status. (Homeida et al., 1979)
In a more recent study, the authors analyzed the negative impact of malnutrition on the
incidence of malaria and on the drug efficacy of sulfadoxine-pyrimethamine (an antimalarial
drug) in a cohort study in northern Ghana. Compared to nutritionally sufficient children,
incidence for malaria was higher in malnourished children. Equally important, the protective
efficacy of sulfadoxine-pyrimethamine was roughly half or even less in the same malnourished
cohort. (Danquah et al., 2009)
Nutrient-drug interactions in humans depend on a wide variety of external and internal
factors. Key pathophysiological and pharmacokinetic attributes may be altered by both macroand micro-nutrient deficiencies. Earlier studies in both laboratory animals and malnourished
human populations have suggested that host nutritional status and dietary factors significantly
influence absorption, tissue uptake, plasma protein bonding, drug distribution, biotransformation,
and rate of excretion from the body. (Krishnaswamy, 2003) If poor nutritional status and host
diet affects anthelminthic efficacy, such findings could be extremely relevant to hookworm
control efforts in resource-limited settings. In regions where malnutrition is prevalent,
albendazole may not achieve its maximum effect.
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Study Objectives
Diet and nutritional status of individuals have been shown to affect response to
benzimidazoles in animal models and may also be principal factors in humans. The effects off
low dietary energy, protein deficiency, and malnutritional state may modify drug metabolism and
thus negatively influence intensity and duration of drug action. It has been shown that the
anthelminthic efficacy of mebendazole is decreased in combined iron and protein deficiency
states—these results raise the possibility that mebendazole acts synergistically with the immune
system. (Duncombe et al., 1977) As protein and iron deficiency often coexist with heavy worm
infestations, it may be that these nutrient deficiencies potentiate the infestation, thus explaining
the lack of success of some control programs. With an in-depth focus on modifiable host factors
affecting anthelminthic efficacy, the objectives of the study include:
1. Describing the epidemiology of hookworm infection and responses to albendazole
treatment in the Kintampo North District
2. Evaluating the relationship of nutritional status and diet as they influence treatment
efficacy
3. Identifying modifiable host factors affecting response to treatment

21

Methods
Ethical Review and Oversight
Both field and laboratory components of the epidemiology project were approved by the
Human Investigation Committee (HIC) at Yale University (protocol number 07050022669) and
institutional review boards within the Ghana Health Service, the Noguchi Memorial Institute for
Medical Research (NMIMR), and the Kintampo Health Research Centre (KHRC). The study
protocol used the following inclusion criteria: 1) an enrolled student at the respective primary
school, 2) residing within the study area, 3) between the ages of 6 and 13, and 4) willing and able
to give informed consent. Exclusion criteria included participation in a hookworm disease study
within the past two years.
Preliminary steps for subject recruitment in the Kintampo North Municipality included
meetings with the Kintampo office of the Ministry of Education to discuss the study protocol.
Previously identified as having high prevalence of hookworm infection, five villages along the
Techiman-Tamale Road were chosen to participate in the survey (Figure 3). Further meetings
with local community leaders were held to address the specific aims of the study, and following
their approval, community meetings were organized with eligible school-age children and their
parents/guardians. Written consent forms in both English and Twi were provided for any
prospective subject. All consent forms and survey instruments (e.g., questionnaire) were
translated into Twi and back-translated into English to ensure validity.
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Study Design
Setting – Study Area and Population
The study presented here was conducted from June to August 2011 in the Kintampo
North Municipality of the Brong Ahafo Region (Figure 3). The region is mostly rural plains
with low hills and few rivers. Most of the population is involved in agriculture and subsistence
farming, clean water and sanitation infrastructure are lacking in communities, and helminth
infections are prevalent among children. In each village along the Techiman-Tamale Road, there
was a primary school with pupils within different grade levels. Intestinal helminth infections are
dominated by hookworms in the study area.

Figure 3. Techiman-Tamale Road, north of Kintampo, Ghana
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Subjects
The study population consisted of children 6- to 13-years-old selected from five
communities (north to most southern): Atta, Chiranda, Jato, Mahama, and Tahiru. Given the
available resources, sample size calculations determined that 125 children must be included to
provide 80 percent power. However, the sample size was increased to 150 children to allow for
losses at follow-up and missing data. The final sample size was 141 eligible child participants.

Surveying Instruments
Parasitological Diagnosis and Treatment
After preliminary consent meetings and laboratory preparations, the baseline
parasitological survey was conducted in mid-June 2011. At enrollment, 500 mL plastic
containers labeled with unique identification codes were distributed to study participants. They
were asked to collect and deposit large, fresh portions of their morning stools into the containers,
which were then sealed and brought to school. Containers were collected in front of the school
building by the research team and transported back to the central laboratory at the health research
center for immediate processing.
At the laboratory, collected stool samples were examined to determine the presence of
hookworm infection. Individual stools were analyzed by the Kato-Katz fecal thick smear
technique (Katz et al., 1972) for estimation of eggs per gram (EPG) of feces. After preparation
of thick smears, they were counted under light microscopes by laboratory personnel. Egg counts
were multiplied by a factor of 24 to express the number of eggs per gram of stool sample. Each
child was asked to provide another fecal sample the following day. A single slide was prepared
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and read from each day’s fresh stool sample—for a total of two slides presented as the mean egg
count for each child.
Following microscopic examination of the stools and diagnosis, hookworm-infected
children received albendazole, orally administered, at a single dose of 400 mg. Treatment was
supervised by a local pharmacist from the Kintampo Municipal Hospital. Approximately two
weeks after albendazole had been administered to hookworm-infected study participants, two
stool specimens were again collected with the same field and laboratory procedures as described
above. At the end of the follow-up survey, children who remained infected with hookworm eggs
were treated with another dose of albendazole.

Anthropometry
Anthropometric measurements of each study participant were obtained at a central
screening site. Weight was measured to the nearest 0.1 kg using an electronic balance and height
was measured to the nearest 0.1 cm using a portable fixed stadiometer. From the height and
weight measurements, body mass index (BMI) was calculated as [weight (kg)] / [height (m)]2
and converted to BMI-for-age z-scores with WHO AnthroPlus software. The measurement of
mid-upper arm circumference (MUAC) is a simple screening method to determine nutritional
status and it is a useful indicator for estimating prevalence of malnutrition of a population.
(WHO, 2009) MUAC was measured to nearest 0.1 cm at the midpoint of the left arm with a
standardized tape ribbon. According to the World Health Organization, children with a MUAC
less than 115 mm have a highly elevated risk of morbidity and mortality compared to those who
are above. Measures below 115 mm are indicative of severe wasting. (WHO, 2009)
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Evaluation of Hemoglobin Levels
Iron status was assessed by hemoglobin (Hb) and serum ferritin (SF), currently
considered as the most efficient indicators of iron status. Hb can be used to diagnose anemia, a
specific condition where red blood cells provide inadequate amounts of oxygen to tissues, which
can be caused by nutritional iron deficiency and anemia arising from parasitic infections.
(Mei et al., 2005) Anemia was defined as Hb levels falling below 11.0 g/dL. (WHO, 2008)
Laboratory technicians from the Kintampo Municipal Hospital collected venous blood from each
study participant in separate 5 mL tubes at a central location. Participants were provided a sugar
biscuit and a can of condensed milk after blood draw. Initial blood tests were performed at
KHRC laboratories. Malaria antigen detection tests and thick and thin blood smears were also
used to examine for the presence of Plasmodium falciparum. Unused serum samples were
frozen for further analyses.

Household Survey
Two individual field teams of researchers and translators conducted home interviews
between June and August 2011. A pre-tested standardized questionnaire was used to gather
socioeconomic information, including types of household construction, sources of water and
sanitation, level of parental education and occupation, and ownership of select household assets
(e.g., land, automobiles, and livestock). In addition, measures of food security, dietary diversity,
and details of medical history were collected as part of the individual survey.
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Cross-sectional food recalls were used to determine dietary diversity scores and describe
dietary patterns among study participants—with two 24-hour dietary recalls on two separate
occasions, spaced approximately four weeks apart. Although recalling two days does not cover
all day-to-day variations of dietary intake, using two non-consecutive days over a period of four
weeks significantly enhances the food recall coverage. Food recall questionnaires were the ideal
instruments for population survey and were culturally appropriate, reliable, and valid in
obtaining dietary data. Examples of food items were modified to reflect food items unique to the
region. During each household visit, both the child and parent/guardian were asked to respond to
the questionnaire to improve accuracy of the child’s dietary recall. To be counted as a
“consumer” of any category, the child had to have consumed at least a half-serving of the food
group at any time during the previous 24 hours.

Methodology and Assessment of Nutritional Status and Dietary Factors
Isolating the effect of host nutritional status on efficacy of albendazole required the
precise measurement of nutrient intake. An individual dietary diversity score is a standard
measure and functional proxy of dietary quality. (Arimond and Ruel, 2004) To calculate a
dietary diversity score, the number of different groups consumed is summed for a total. For
example, a sum of five different food groups implies a diet that offers some diversity in both
macro- and micro-nutrients.
A diversified diet is highly correlated with factors, such as caloric and protein adequacy,
percentage of high-quality protein, and improved food consumption. Dietary diversity can also
serve as a marker of physical growth, cognitive development, and health outcomes. (Arimond
and Ruel, 2004) The following set of 18 food groups was derived from the Food and Nutrition
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Technical Assistance Project and was used to calculate individual dietary diversity score within
the study population:
A.
B.
C.
D.
E.
F.
G.
H.
I.

Milk
Tea, Coffee, Cocoa
Other Liquids
Grains
Orange or Yellow Vegetables
Tubers
Green Vegetables
Vitamin A-rich Fruits
Other Fruits and Vegetables

J.
K.
L.
M.
N.
O.
P.
Q.
R.

Organ Meats
Meats
Eggs
Fish
Legumes
Cheese or Yogurt
Red Palm Oil-based Foods
Butter and Oils
Sweets

The total number of consumed food groups are then added together to indicate a score between 0
and 18:
Sum (A + B + C + D + E + F + G + H + I + J + K + L + M + N + O + P + Q + R)
A score of 0 indicates that the child had eaten nothing from any of the 18 food groups whereas a
value of 18 indicates all food groups had been consumed within the reference period. Data for
the dietary diversity score was collected by asking the respondent a series of yes-no questions
using the previous 24 hours as a reference period to minimize recall limitations.

Data Analysis
Only those study participants with complete data sets were retained for full data analysis.
Data was entered into Microsoft Excel and analyzed by SAS software (version 9.2). Univariate
analyses were performed for descriptive purposes and summaries of baseline and post-treatment
populations. Chi-squared tests were used to test for differences between populations and groups.
Ordered logistic regression was also preformed to identify predictors of egg reduction rate.
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The response to treatment of soil-transmitted helminth infections is expressed by two
standard indicators: the egg reduction rate and the cure rate. (Vercruysse et al., 2011) The egg
reduction rate is described as the percentage decrease from pre-treatment to post-treatment levels.
(Anantaphruti et al., 2007) The egg reduction rate is calculated as follows:
Mean EPG before treatment – Mean EPG after treatment * 100%
Mean EPG before treatment
Similarly, the cure rate for the study population was calculated as the percentage or prevalence of
children with EPG counts greater than zero before treatment and zero EPG counts after
treatment:
Prevalence before treatment – Prevalence after treatment * 100%
Prevalence before treatment
Ordered logistic regression was used for predicting increasing levels of egg reduction rate
with both continuous and categorical variables. The final model included variables of statistical
significance (p-value < 0.05).
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Results
Study Population Characteristics
The study population included 141 eligible school-age children, ranging from 6- to 13years-old from 5 different villages along the Techiman-Tamale Road (Figure 4).

Figure 4. Study population characteristics
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The mean age of study participants was 9.6 years. There was a nearly even distribution
of males (48.2%) and females (51.8%). From the participating households, 96.4% owned
agricultural land and 31.4% reported owning any type of savings account. As a reliable measure
of a socioeconomic status, an absolute wealth index was constructed based on asset ownership
(e.g., automobile, agricultural land, livestock) for each household. (Brooker et al., 2007) Based
on a maximum index of 18 units, the mean absolute wealth index for the study population was
6.8. Atta, the most northern school, had the lowest mean absolute wealth index (5.9) and Tahiru,
the most southern school, had the highest mean of the study population (7.5) (Figure 5).
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Figure 5. Mean absolute wealth index by school (from north to south)
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Across the study population, 82.3% of households treated their drinking water and only
31.9% had access to a pit latrine. Of those owning mosquito nets (91.5%), 93.8% of index
children reported sleeping under the net the previous night. The main occupation of head of
households was agricultural farming (88.9%).

Nutritional Profile of the Study Population
Preliminary findings indicate many study participants consume low-quality roots and
tubers—a monotonous and bulky diet is the hallmark of poverty and poor nutrition. Diets were
sometimes supplemented with vegetables and legumes, but rarely with animal-source protein
(Figure 6). With respect to weekly consumption, only 41% of respondents reported consuming
meats—and less than 21% consumed organ meats, orange and yellow vegetables, and vitamin Arich fruits.
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Weekly Consumption of Food Groups by the Study Population
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Figure 6. Weekly consumption of food groups by the study population

Independent of socioeconomic status, dietary diversity has been associated with child
nutritional status and often serves as a functional proxy of dietary intake. (Arimond and Ruel,
2004) The mean weekly dietary diversity score across the study population was 10.5—Jato had
the lowest mean (8.9) whereas Atta had the highest mean (11.4) (Figure 7 and Figure 8).
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Weekly Dietary Diversity Scores of the Study Population
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Figure 7. Weekly dietary diversity scores of the study population
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Mean Weekly Dietary Diversity Score by School
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Figure 8. Mean weekly dietary diversity score by school
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Although the study population heavily consumed carbohydrate staples, such as yams and
cassava, they were limited in dietary protein and iron. The mean weekly dietary protein intake of
the study population was only 3.3 out of a maximum 7 protein-rich food groups (Figure 9).
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Figure 9. Weekly dietary protein intake by the study population
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Again, Jato had the lowest mean of weekly dietary protein intake (2.8) (Figure 10).
Mean Weekly Dietary Protein Intake by School
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Figure 10. Mean weekly dietary protein intake by school
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Survey Results
At baseline, the overall prevalence for hookworm infection was 57.4%. By school, rates
of infection ranged from 40.9% in Tahiru to 77.8% in Mahama (Figure 11).
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Figure 11. Prevalence of hookworm infection by school

The arithmetic mean fecal egg count was 429.4 (+ 640.8) with counts ranging between 12 EPG
to 3,216 EPG in infected children. According to the World Health Organization’s classification
of level of intensity, 96.2% of infected children had light infections (1 – 1,999 EPG) whereas
only 3.8% children had moderate infections (2,000 – 3,999 EPG). (Montresor et al.) There were
no heavy infections (> 4,000 EPG) in the study population at baseline (Table 1).
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Table 1. Intensity of Hookworm Infection
Classificationa
N (%)b
Light
77 (96)
Moderate
3 (4)
Heavy
0 (0)
a

Based upon WHO criteria (Light infection: 1 – 1,999 EGP; moderate infection: 2,000 – 3,999 EPG;
heavy infection: > 4,000 EPG)
b
Numbers may not sum to total due to missing data

The prevalence of hookworm and malaria co-infection in the study population was 54.6%
and, by school, ranged from 34.6% in Chiranda to 77.8% in Mahama (Figure 12). Hookworm
and malaria co-infection may produce compounded deficits in hemoglobin. (Hotez, 2006) In
addition, the overlapping distribution of malaria infection with hookworm may adversely affect
host immune response. (Brooker et al., 2004)
Prevalence of Hookworm and Malaria Co-Infection by School
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Figure 12. Prevalence of hookworm and malaria co-infection by school
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Parasitic co-infection remained highly endemic in the region—only 5% of the entire study
population was negative for both hookworm and malaria infection. As determined by
hemoglobin levels falling below 11.0 g/dL, 28.1% of study participants were anemic.

Characterization of the Study Population as Defined by Hookworm Infection
Status at Baseline
Univariate analysis was conducted to determine risk factors of acquiring hookworm
infection. Statistically significant associations between study characteristics and hookworm
infection (p-value < 0.05) are described in the following tables. Comparing anthropometric
indicators and nutritional status of the study population, age, sex, and MUAC were associated
with hookworm infection at baseline (Table 2).
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a

Table 2. Anthropometric Indicators and Nutritional Status of the Study
Population by Hookworm Infection Status at Baselinea
Hookworm Infection
Characteristic
Positive (N = 81)b
Negative (N = 60)b
Age (years)
10.1 + 1.6
9.4 + 1.6
Sex
Male
55.6 (45)
38.3 (23)
Female
44.4 (36)
61.7 (37)
Household Food Insecurity
Low
25.9 (21)
35 (21)
Moderate
37.0 (30)
45 (27)
High
37.0 (30)
20 (12)
Weekly Dietary Diversity
Low
28.4 (23)
30 (18)
Moderate
40.7 (33)
31.7 (19)
High
30.9 (25)
38.3 (23)
Weekly Dietary Protein
Low
40.7 (33)
33.3 (20)
Moderate
30.9 (25)
30 (18)
High
28.4 (23)
36.7 (22)
BMI-for-age Z-score
-0.58 + 2.0
-0.89 + 0.7
MUAC
19 + 1.5
18.4 + 1.5

pc
0.0163
0.043

0.088

0.505

0.535

0.264
0.0221

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b

41

Demographic and socioeconomic indicators associated with hookworm infection at
baseline were location of village, daily shoe usage, and waste on property (Table 3). Waste on
property was assessed by the interviewer during the first round of household visits. Without
involving the respondent, the interviewer personally answered the yes-no question, “Is there
noticeable garbage around the household?” by observing for physical waste on the property. Pit
latrine usage was not a statistically significant association.

a

Table 3. Demographic and Socioeconomic Indicators of the Study
Population by Hookworm Infection Status at Baselinea
Hookworm Infection
Characteristic
Positive (N = 81)b
Negative (N = 60)b
Village
Atta
28.4 (23)
30 (18)
Chiranda
13.6 (11)
25 (15)
Jato
29.6 (24)
16.7 (10)
Mahama
17.3 (14)
6.7 (4)
Tahiru
11.1 (9)
21.7 (13)
Absolute Wealth
Low
27.2 (22)
28.3 (17)
Moderate
39.5 (32)
38.3 (23)
High
33.3 (27)
33.3 (20)
Daily Shoe Usage
Yes
45.7 (37)
65 (39)
No
54.3 (44)
35 (21)
Pit Latrine Usage
Yes
25.9 (21)
40 (24)
No
74.1 (60)
60 (36)
Waste on Property
Yes
40 (32)
22 (13)
No
60 (48)
78 (46

pc
0.0346

0.986

0.0229

0.0763

0.0253

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b
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Anemia (Hb < 11.0 g/dL) was associated with hookworm infection at baseline (Table 4).
Healthcare access and anthelminthic treatment within the past year were not significant
associations.

a

Table 4. Health Indicators of the Study Population by Hookworm Infection Status
at Baselinea
Hookworm Infection
Characteristic
Positive (N = 81)b
Negative (N = 60)b
Healthcare Access
Within one year
41.8 (33)
55.9 (33)
More than one year
54.4 (43)
39 (23)
Never
3.8 (3)
5.1 (3)
Malaria Infection Status
Positive
95.1 (77)
88.3 (53)
Negative
4.9 (4)
11.7 (7)
Hemoglobin Levels (g/dL)
> 11.0
21.3 (17)
37.3 (22)
< 11.0
78.8 (63)
62.7 (37)

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b
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pc
0.199

0.141

0.0375

Study participants reporting moderate and high household food insecurity had a greater
prevalence of hookworm infection at baseline than those reporting lower household food
insecurity (Figure 13).

Prevalence of Hookworm Infection at Baseline by Household Food Insecurity
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Figure 13. Prevalence of hookworm infection at baseline by tertiles of household food
insecurity
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The median weekly dietary diversity score of the study population at baseline was 10.0.
Children falling below the median had higher rates of hookworm infection than those above the
median (Figure 14). Similarly, participants below the study population median of weekly dietary
protein intake (3.0) experienced higher rates of hookworm than those above the median (Figure
15).
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Figure 14. Prevalence of hookworm infection at baseline by weekly dietary diversity
score (as defined by the median)
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Prevalence of Hookworm Infection at Baseline by Weekly Dietary Protein Intake
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Figure 15. Prevalence of hookworm infection at baseline by weekly dietary protein
intake (as defined by the median)
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Low protein consumption in the study population may be an important predictor of
hookworm infection. The dose-response effect was characterized by protein consumption
expressed in tertiles, such that subjects in the lowest tertile had higher rates of infection than
those in upper tertiles (Figure 16).

Prevalence of Hookworm Infection at Baseline By Weekly Dietary Protein Intake
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Table 16. Prevalence of hookworm infection at baseline by tertiles of weekly dietary
protein intake
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Characterization of the Study Population as Defined by Hookworm Infection
Status Post-Treatment
For post-treatment analysis, univariate statistics again described associations between
study population characteristics and hookworm infection status after administration of
albendazole. Weekly dietary diversity was the only statistically significant association seen
between nutritional status and post-treatment hookworm infection status (Table 5).

a

Table 5. Anthropometric Indicators and Nutritional Status of the Treatment
Population by Post-Treatment Hookworm Infection Statusa
Hookworm Infection
Characteristic
Positive (N = 49)b
Negative (N = 29)b
Age (years)
9.9 + 1.7
10.4 + 1.5
Sex
Male
61.2 (30)
48.3 (14)
Female
38.8 (19)
51.7 (15)
Household Food Insecurity
Low
28.6 (14)
24.1 (7)
Moderate
32.7 (16)
37.9 (11)
High
38.8 (19)
37.9 (11)
Weekly Dietary Diversity
Low
40.8 (20)
10.3 (3)
Moderate
36.7 (18)
44.8 (13)
High
22.5 (11)
44.8 (13)
Weekly Dietary Protein
Low
46.9 (23)
34.5 (10)
Moderate
28.6 (14)
34.5 (10)
High
24.5 (12)
31 (9)
BMI-for-age Z-score
-0.43 + 2.5
-0.85 + 0.56
MUAC
18.7 + 1.4
19.3 + 1.6

pc
0.221
0.265

0.868

0.0111

0.559

0.398
0.069

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b
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As demographic and socioeconomic indicators of the treatment population, location of
village and waste on property were significantly associated with post-treatment hookworm
infection (Table 6).

a

Table 6. Demographic and Socioeconomic Indicators of the Treatment
Population by Post-Treatment Hookworm Infection Statusa
Hookworm Infection
Characteristic
Positive (N = 49)b
Negative (N = 29)b
Village
Atta
12.2 (6)
55.2 (16)
Chiranda
4.1 (2)
31 (9)
Jato
49 (24)
0 (0)
Mahama
20.4 (10)
10.3 (3)
Tahiru
14.3 (7)
3.5 (1)
Absolute Wealth
Low
28.6 (14)
27.6 (8)
Moderate
36.7 (18)
41.4 (12)
High
34.7 (17)
31 (9)
Daily Shoe Usage
Yes
42.9 (21)
48.3 (14)
No
57.1 (28)
51.7 (15)
Pit Latrine Usage
Yes
18.4 (9)
38 (11)
No
81.6 (40)
62.1 (18)
Waste on Property
Yes
43.8 (21)
37.9 (11)
No
56.3 (27)
62.1 (18)

pc
< .0001

0.913

0.642

0.0558

0.0253

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b
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With respect to surveyed health indicators, only malaria infection status was significantly
associated with post-treatment hookworm infection (Table 7). Again, healthcare access and
anthelminthic treatment within the past year were not associated with post-treatment hookworm
infection status.

a

Table 7. Health Indicators of the Treatment Population by Post-Treatment
Hookworm Infection Statusa
Hookworm Infection
Characteristic
Positive (N = 49)b
Negative (N = 29)b
Healthcare Access
Within one year
36.2 (17)
44.8 (13)
More than one year
57.5 (27)
55.2 (16)
Never
6.4 (3)
0 (0)
Malaria Infection Status
Positive
100 (49)
89.7 (26)
Negative
0 (0)
10.3 (3)
Hemoglobin Levels (g/dL)
> 11.0
24.5 (12)
17.2 (5)
< 11.0
75.5 (37)
82.8 (24)

pc
0.332

0.0217

0.454

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b
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Study participants residing in households with high household food insecurity
experienced greater rates of post-treatment infection than those in both moderate and low
reporting households (Figure 17).

Prevalence of Post-Treatment Hookworm Infection by Household Food Insecurity
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Figure 17. Prevalence of post-treatment hookworm infection by tertiles of household
food insecurity

51

Overall Drug Efficacy
Cure Rate and Egg Reduction Rate
Only hookworm-infected cases were assessed for the curative efficacy of albendazole.
The egg reduction rate was also analyzed. Administration of albendazole produced substantial
cure rates and reduction of hookworm egg counts, although there were a wide variety of results
(Figure 18). Out of those identified as hookworm-positive at baseline and received treatment
(N = 79), 49 children remained infected—a cure rate of 37.2% (Table 8).
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Figure 18. Prevalence of hookworm infection at baseline and post-treatment by school
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Jato, a community previously identified with the lowest mean dietary diversity and
protein intake in the study population, not only experienced a zero cure rate, but had extremely
poor mean egg reduction rates after treatment with albendazole (Figure 19). Atta and Chiranda
had mean egg reduction rates of 94.3% and 96.3%, respectively, but in contrast, Jato had a mean
egg reduction rate of only 1.2%.
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Figure 19. Mean egg reduction rate by school
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Although 81 children were positive for hookworm infection at baseline, 79 received
albendazole treatment with 2 lost at follow-up. Compared to 429.4 (+ 640.8) at baseline, the
arithmetic mean fecal egg count after treatment was 170.2 (+ 434.6)—an egg reduction rate of
60.4% (Table 8).

Table 8. Hookworm Cure Rate and Egg Reduction Rate of the Treatment Group
Prevalence (%)
Baseline
100
Post-Treatment
62.8
Cure Rate (%)
37.2
a
Arithmetic Mean Egg Count
Baseline
429.4 + 640.8
Post-Treatment
170.2 + 434.6
Egg Reduction Rate (%)
60.4
a

Eggs per gram

Assessment of Nutritional Status and Host Factors on Treatment Efficacy
The following assessment reviews the treatment population’s dietary intake and hostrelated factors as surveyed on the day albendazole administration. Throughout the remainder of
the study, dietary intake on “treatment day” refers explicitly to the 24 hour reference period prior
to receiving albendazole. Although previous reports have shown that protein and calorie
malnutrition reduce drug efficacy, the magnitude of dietary diversity and protein intake on days
of treatment have not been well studied. (Mao et al., 2006) Identifying risk factors responsible
for low cure rate and egg reduction rates may provide clearer insight into how host nutritional
status and dietary factors can improve response to treatment.
With respect to post-treatment hookworm infection status, negative cases consumed a
greater number of food groups than positive cases (Figure 20). A larger proportion of
hookworm-negative cases ate more amounts of different food groups than hookworm-positive
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cases. It was notable that zero post-treatment hookworm-positive cases consumed organ meats,
vitamin-A rich fruits, and cheese and yogurt during the reference period.
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Figure 20. Food group consumption by treatment group on treatment day
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Dietary diversity scores of post-treatment hookworm-positive cases ranged from 2 to 9 on
treatment day whereas scores of post-treatment hookworm-negative cases ranged from 3 to 16
(Figure 21). Hookworm-infected children’s diets during the reference period were less diverse
than those of uninfected children (p-value 0.0016). Dietary diversity may be a significant host
factor contributing to increased morbidity and poorer cure rate in the study population.

Dietary Diversity Scores on Treatment Day
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Figure 21. Dietary diversity scores on treatment day—post-treatment hookwormpositive cases versus post-treatment hookworm-negative cases
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Similar to food group consumption on treatment day, hookworm-negative cases
consumed a larger proportion of protein-rich food groups than hookworm-positive cases (Figure
22). Those who consumed organ meats and fish during the reference period experienced a
statistically significantly higher rate of successful deworming on treatment day.
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Figure 22. Protein-rich food group consumption by treatment group on treatment day
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Dietary protein intake on treatment day ranged from 0 to 3 protein-rich food groups for
hookworm-positive cases and 1 to 5 for hookworm-negative cases. Nine children from the
treatment population consumed zero protein-rich food groups prior to treatment—and all nine
remained hookworm-positive after administration of albendazole (Figure 23).
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Figure 23. Dietary protein intake on treatment day—post-treatment hookworm-positive
cases versus post-treatment hookworm-negative cases
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As seen in Figure 24, dietary protein intake patterns notably decrease from the entire
study population to hookworm-positive infection status at baseline and finally to post-treatment
cases. The effects of low dietary protein intake may play a role not only in susceptibility to
hookworm infection, but also treatment response.

Mean Weekly Dietary Protein Intake by School
5

Protein-Rich Food Groups

4

3

2

1

0
Atta

Chiranda

Jato

Mahama

Tahiru

School
Study Population

Hookworm-Positive at Baseline

Hookworm-Postive Post-Treatment

Figure 24. Mean weekly dietary protein intake of the study population, hookwormpositive cases at baseline, and hookworm-positive cases post-treatment (left to right)
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Weekly dietary diversity, as an indicator of nutritional status, was significantly associated
with post-treatment hookworm infection status (p-value 0.0111). The median weekly dietary
diversity score of the treatment population was 10.0—those falling below the median had higher
rates of post-treatment hookworm infection than those above the median (Figure 25).
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Figure 25. Prevalence of post-treatment hookworm infection by weekly dietary diversity
score
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The association between weekly dietary diversity and post-treatment hookworm infection
status was also seen as a dose-response relationship between tertiles—infection clearance was
more successful among children in the highest tertile of dietary diversity (Figure 26).
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Figure 26. Prevalence of post-treatment hookworm infection by tertiles of weekly
dietary diversity score
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To further investigate the role of dietary diversity on treatment response, scores were
tabulated with respect to the previous 24 hours prior to administration of albendazole. The
median dietary diversity score of the reference period prior to treatment was 5.0 food groups—
children following below the median had considerably lower rates of hookworm clearance than
those above the median (Figure 27). Out of 24 children falling below the median, 21 remained
positive for hookworm infection after treatment. Cases with dietary diversity scores above the
median had better responses to drug therapy and a higher a cure rate.
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Figure 27. Prevalence of post-treatment hookworm infection by dietary diversity score
on treatment day
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The median protein-rich food groups consumed on treatment day was 1.0—all treatment
participants falling below the median remained positive for hookworm (Figure 28). Those above
the median showed a better response to albendazole and had a higher cure rate.
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Figure 28. Prevalence of post-treatment hookworm infection by dietary protein intake
on treatment day
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Study characteristics surveyed on treatment day included dietary diversity score, dietary
protein intake, the number of bowel movements within the past 24 hours, presence of diarrhea or
loose stools within the past 24 hours, and time since last meal (Table 9). Dietary diversity score
and dietary protein intake, characterized by tertiles, within the reference period were
significantly associated with post-treatment hookworm infection status. In addition, time since
last meal was associated with presence of remaining infection after treatment—those who did not
eat for more than six hours prior to receiving albendazole had better response to treatment
(p-value 0.0016).

a

Table 9. Nutritional Status and Dietary Factors of the Treatment Population by
Post-Treatment Hookworm Infection Statusa
Hookworm Infection
Characteristic
Positive (N = 49)b
Negative (N = 29)b
Dietary Diversity Score on
Treatment Day
Low
42.9 (21)
10.3 (3)
Moderate
26.5 (13)
37.9 (11)
High
30.6 (15)
51.7 (15)
Dietary Protein Intake on
Treatment Day
Low
18.4 (9)
0 (0)
Moderate
53.1 (26)
58.6 (17)
High
28.6 (14)
41.4 (12)
Diarrhea
Yes
18.4 (9)
37.9 (11)
No
81.6 (40)
62.1 (18)
Number of Bowel Movements
within 24 Hours
1.06 + 0.69
1.52 + 1.18
Did Not Eat for More than 6
Hours Prior to Treatment
Yes
10.4 (5)
41.4 (12)
No
89.6 (43)
58.6 (17)

pc
0.0104

0.0423

0.0558

0.0344

0.0016

Table values are mean + SD for continuous variables and column % (N) for categorical variables
Numbers may not sum to total due to missing data and percentages may not sum to 100% due to
rounding
c
2
p-value is for t-test (continuous variables) or x -test (categorical variables)
b
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To perform an ordered logistic regression analysis, egg reduction rate was ordered into
increasing levels:
No Reduction (0% egg reduction)
Low Reduction (1% to 50% egg reduction)
Moderate Reduction (51% to 75% egg reduction)
High Reduction (76% to 100% egg reduction)
Children with higher dietary diversity scores on treatment day were 3.08 times more likely than
those with lower scores to experience the highest egg reduction rates (p-value 0.0430)
(Table 10 ).

Table 10. Potential Host Factors Predicting Increasing Egg Reduction Rate with
Treatmenta
Characteristic
Adjusted Odds Ratio
95% CI
pc
Sex
Male
1.00
Female
0.65
(0.26, 1.61)
0.353
Time Since Last Meal
Ate Within 6 Hours Prior to
Treatment
1.00
Did Not Eat for More than
6 Hours Prior to Treatment
4.95
(1.24, 19.80) 0.0239
Diarrhea
Yes
1.00
No
0.32
0.0523
Dietary Diversity Score on
Treatment Day
Low
1.00
Moderate
1.42
(0.48, 4.22)
0.530
High
3.08
(1.04, 9.15)
0.0430
Dietary Protein Intake on
Treatment Day
Low
1.00
Moderate
1.70
(0.43, 6.71)
0.448
High
2.62
(0.60, 11.38)
0.200
a

Adjusted for sex, age, and absolute wealth index
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A Potential Fasting-Induced Effect to Albendazole Treatment
On treatment day, each study participant reported time since last meal which was then
calculated into hours by the interviewer. Those who had not eaten for more than six hours prior
to treatment displayed a better response to albendazole than those who ate within six hours prior
to receiving albendazole (Figure 29). A possible hypothesis to explain the potential effect of
fasting may be that albendazole is more effective in a fasting individual due to resultant higher
drug concentration in the gut. The influence of fasting on the bioavailability and
pharmacokinetics of albendazole warrants further investigation.
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Figure 29. A potential fasting-induced effect to albendazole treatment response
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Discussion
Nutritional Status of the Treatment Population
Providing sufficient food and nutrition to meet people’s basic needs for health, growth,
and development has been a long-standing challenge for African countries. Dietary diversity has
shown to be positively linked to nutrient adequacy and improved health status in individuals.
The traditional rural Ghanaian diet disproportionately comprises of staple foods at the expense of
dietary diversity. In addition to placing young children at risk for chronic malnutrition and
nutrient deficiencies, high consumption of cereal-based diets and low consumption of proteinrich foods may lead to reduced effectiveness of chemotherapeutic schemes for hookworm.
Previous literature has identified an association between host nutritional status and susceptibility
to hookworm infection, but the same association with anthelminthic efficacy of albendazole
remains unclear.
Weekly consumption of food groups by the study population indicates participating
children consume a limited diet of cereals and tubers also lacking in protein-rich foods. A wide
range of foods is the best source of essential nutrients—less than half of the children consumed
milk, meats, cheese or yogurt, eggs, organ meats, orange and yellow vegetables, and vitamin Arich fruits. In addition to reporting both the lowest mean weekly dietary diversity and protein
intake of the study population, Jato had the second highest prevalence of hookworm infection at
baseline (70.6%) and more disturbingly, exhibited a zero cure rate and extremely low mean egg
reduction rate (1.2%) after treatment.
Similar to hookworm cases at baseline, those in the highest tertile of household food
insecurity had the highest prevalence of post-treatment hookworm infection (38.8%). Low food
security indicates chronic hunger and reduced food intake in individuals, which adversely affect

67

health outcomes and physiological function. The association between weekly dietary diversity
and post-treatment hookworm infection was also displayed as dose-response relationship—
hookworm clearance was more successful among children falling in the highest tertile of dietary
diversity (Figure 26). The difference in means of consumed protein-rich food groups on
treatment day was statistically significant (p-value 0.0077) between post-treatment hookwormpositive (1.12) and hookworm-negative children (1.69). Likewise, the difference in means of
dietary diversity score between post-treatment hookworm-positive (5.0) and hookworm-negative
(6.6) was statistically significant (p-value 0.0016).
It is surprising how seldom host nutritional status and dietary factors are described in
treatment regimens, especially for drugs used for infectious disease where malnutrition is widely
prevalent. As specific nutrients are involved in microsomal enzyme systems, capacity for drug
metabolism is reduced in deficient states of nutrition and protein intake. In addition, drug
distribution and clearance are likely to be influenced by malnutrition. (Santos et al., 2005) A
variety of mechanisms may be responsible for the role of reduced efficacy in nutrition deficient
subjects—poor status may affect drug absorption, drug metabolism, and drug uptake by the
intestinal parasite.

68

The Effects of Host Nutritional Status and Dietary Factors on Treatment Efficacy
as Defined by Egg Reduction Rate
Intestinal nematode infections, particularly hookworm, are of major public health
importance in developing countries due to its toll on morbidity—the overall burden of
hookworm disease, as assessed by DALYs, currently outranks African trypanosomiasis, dengue,
Chagas’ disease, schistosomiasis, and leprosy. (Hotez et al., 2004) Individuals harboring large
numbers of adult worms may suffer from poor iron status and iron deficiency anemia—the
hallmark of hookworm disease (Hotez, 2006) Although large-scale deworming efforts may
offer better health outcomes, such as improvements in physical growth and reduced helminth
transmission, reinfection often occurs within only a few months after treatment. In addition,
periodic chemotherapy may increase occurrence of genetically-mediated drug resistance.
(Albonico et al., 2004) The identification of new tools and approaches are needed for the
successful control of hookworm.
Based on previous literature reviewing iron and protein deficiency as modifiers of worm
expulsion in animal models, the primary objective of the study was to investigate whether host
nutritional status and dietary factors did affect response to albendazole in a population where low
cure rates have been reported. (Duncombe et al., 1977; Duncombe et al., 1979) More broadly,
we aimed to review the elements that may play a role in response to treatment: biological,
physical, and chemical factors which are directly and indirectly influenced by host nutrition and
diet (Figure 30). Bacterial populations in the intestine (biological), gut motility and function
(physical), and the effects of food in the gut (chemical) are some of the participating mechanisms
in response to treatment, but they are all ultimately affected by host nutritional status and dietary
parameters.
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Figure 30. Influences on treatment response

In addition to the consistent epidemiology of hookworm infection in the study population
with previous studies, the results and findings described in our study provide evidence to support
further research into the effect of nutritional status and dietary factors on treatment efficacy of
albendazole. The nutritional status of an individual and the availability of nutrients may be
essential to the regulation of albendazole drug action. In a previous study by Bidlack et al., they
demonstrated nutritional factors, specifically the lack of nutrients including protein,
carbohydrates, fats, and specific vitamins and minerals, altered drug metabolism and efficiency
in human subjects Nutritional factors were reported to affect the regulation of detoxification
systems of the liver (e.g., cytochrome P-450-dependent mixed function oxidase). Restricted
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diets with deficiencies in calories, protein, and other nutritional components may affect drug
mechanisms and its components in unique ways not yet explored at length.
The present study potentially indicates the complex interactions between nutrient
deficiency and anthelminthic efficacy. As shown in Figures 27 and 28, children falling below
the treatment population median of both dietary diversity and protein intake on days of treatment
had poorer responses to albendazole. In the group of hookworm-positive children falling below
the population median of dietary diversity on treatment day, 21 out 24 children (87.5%)
remained positive for infection after treatment. Those in the group above the median of dietary
diversity had higher rates of clearance—only 28 out of 54 children remained positive (51.9%).
Consuming more food groups on treatment day, as indicated by higher dietary diversity scores,
was notably associated with better rates of hookworm clearance after treatment as compared to
those consuming less food groups (p-value 0.0026). These principal findings, never before
described in literature, strongly merit further research.
Prevalence of post-treatment hookworm infection was higher for those with low dietary
protein intake on treatment day— all children falling below the population median of dietary
protein intake remained infected with hookworm following treatment. Those with higher dietary
protein intake (above the population median) had improved response to treatment—42%
successfully cleared intestinal worms with albendazole. Having higher dietary protein intake on
day of treatment, as indicated by the consumption of a larger number of protein-rich food groups
within the 24-hour reference period, was also significantly associated with greater treatment
efficacy compared to those consuming a lesser amount of dietary protein (p-value 0.0141). The
role of protein as a dietary factor stimulating drug metabolism has been previously investigated
and confirmed in experimental studies using human subjects. (Krishnaswamy, 1978) If low
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dietary diversity and protein intake negatively influence response to albendazole then they would
be relevant host factors for treatment efficacy.
In addition to dietary diversity score and protein intake on treatment day, time since last
meal was significantly associated with post-treatment hookworm infection status—those who did
not eat for more than six hours prior to administration of albendazole had better drug response
(p-value 0.0016). “Fasting” prior to treatment may be a physiological and/or biochemical factor
affecting treatment efficacy of albendazole. The effect of not eating for more than six hours
prior to treatment in the population produced improved rates of hookworm clearance—it is
possible that fasting produces fundamental physiologic and biochemical changes within the gut
environment that affect the rate and/or extent of intestinal absorption or permit increased
concentrations of the drug. The presence of food in the stomach may result in competition for
binding sites with the drug. Furthermore, aside from the physical influence of food, the nutrient
content of a meal can profoundly affect drug metabolism. (Santos et al., 2005) Additional
studies are needed to determine the underlying effect of fasting on response to albendazole.

Potential Predictors of Egg Reduction Rate
Albendazole produced substantial reductions in hookworm burdens, but a wide variety of
results occurred across the study population. Low egg reduction rates against hookworm may be
due to a number of factors, such as genetic variations in hookworm subpopulations in endemic
settings. Although there may be some concern about emerging resistance to benzimidazole
anthelminthics, there has been no evidence attributing poor anthelminthic efficacy to drug
resistance in the human populations. (Brooker et al., 2004) There have been reports of low
efficacy of benzimidazole anthelminthics against hookworm in humans, but resistance in
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intestinal nematodes of humans has not been confirmed. (Prichard et al., 2007) Therefore,
identification of modifiable host factors is urgently needed to provide evidence of variation in
drug efficacy and to improve anthelminthic programs and for the development of novel control
approaches against hookworm.
This study indicates that in the treatment population, low dietary diversity and protein
intake significantly reduced the efficacy of albendazole. These results are consistent with studies
conducted by Duncombe et al. in which the authors demonstrated a decreased efficacy of
mebendazole against Nippostrongylus brasiliensis infections in rats consuming a protein
deficient diet. Of note, their findings provided the working hypothesis for our field study
investigating treatment efficacy.
After adjusting for sex, age, and wealth, an ordered logistic regression model identified
potential host factors associated with increasing egg reduction rate in the treatment population—
time since last meal and dietary diversity. Those who did not eat for more than six hours prior to
treatment were 4.95 times more likely to experience higher egg reduction rates than those who
ate prior to treatment (p-value 0.0239). Another host factor was dietary diversity score on
treatment day (within the 24-hour reference period)—those with high dietary diversity were 3.08
times more likely to produce the highest egg reduction rate than those with lower dietary
diversity (p-value 0.0430). The contribution of time since last meal and dietary diversity to
increasing egg reduction rates of albendazole may be biologically relevant host-related factors
for the improved treatment of hookworm.
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Study Limitations
A potential limitation of the present study was the implementation of questionnaires and
its related data collection. Although any recall method is susceptible to bias, collection of
dietary data by trained interviewers and translators reduced recall bias. All responses were
clearly documented to ensure accurate interpretation during data analysis. Another limitation of
this study has to do with the possibility of omitted variables and measurement error. There may
be relevant variables at the individual level that are not included in our study or are not measured
adequately.
The Kato-Katz method is another potential area of concern. To correctly assess the
efficacy of albendazole, the type of diagnostic test is a critical factor due to rapid egg
deterioration. Stool samples were transported to the central laboratory and prepared for readings
immediately after collection from school sites. Despite low negative-predictive power and
variability, the Kato-Katz method is appropriate for the epidemiology survey of hookworm due
to its relative simplicity, low cost, and rapidity. (Katz et al., 1972; Montresor et al.)

Future Directions and Strategies for Control
In the experiments outlined above, there was a statistically significant association
between relatively low dietary diversity and protein intake on treatment day and response to
albendazole. Pathophysiological changes encountered in malnutrition are diverse and
complicated due to parasitic infections with hookworm. A more in-depth focus is needed to
evaluate the influence of nutritional status and food components on treatment regimens. An
imbalance of nutrient intake may have direct clinical relevance such that deficiencies can
interfere with drug processes in the body resulting in altered response.
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Approximately 70% of children who did not eat more than six hours prior to treatment
displayed a better response to albendazole and cleared hookworm infection. The underlying
mechanism of a potential fasting-induced effect demands a closer examination. Fasting prior to
treatment may notably affect the bioavailability and disposition kinetics of albendazole. In a
pharmacological study conducted by Sanchez et al., the authors observed the effects of fasting on
albendazole kinetics in calves—fasting the animals prior to treatment resulted in enhanced
gastrointestinal absorption of the drug compared to fed calves. The authors also report that the
bioavailability and disposition kinetics of albendazole and its metabolites in calves were affected
by fasting. In a separate study, different authors reported that administration of albendazole on
an empty stomach may better elicit intraluminal effects against intestinal parasites. (Lange et al.,
1988) The findings of the present study combined with those by Sanchez et al. and Lange et al.
hold practical implications that warrant further investigation.
Developed countries such as those in North America, Europe, and parts of Asia have
been able to control endemic hookworm, but the same level of success has yet to be witnessed in
at-risk settings (Sub-Saharan Africa) lacking the same engines of economic development.
Although resistance has not yet threatened anthelminthic-based interventions, methods to sustain
drug efficacy, such as nutritional supplementation with iron and protein, are needed to improve
long-term control. According to Koski et al., iron deficiency increased larval growth and adult
survival of Nippostrongylus brasiliensis in animal models, but repletion of iron accelerated
worm expulsion. Effective management of helminth control programs require not only
evaluation of drug quality and combination of products, but a greater awareness of the effect of
nutritional deficiencies and host factors on treatment efficacy.
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The design and implementation of chemotherapy programs in rural communities where
poverty and poor sanitation exist may need to be supported by nutritional intervention during
treatment periods for improved efficacy against hookworm infection. Low dietary diversity and
protein intake can potentially reduce the success of drug interventions and the decreased efficacy
of treatment may promote selection of resistant hookworms. Furthermore, combining
chemotherapy with nutritional intervention may allow for maximal drug effectiveness. The
effects of nutritional supplementation on response to treatment have yet to be fully established
and will require extensive longitudinal studies.

Conclusion
Some determinants of observed low drug efficacy may include reduced absorption and
bioavailability, host-parasite relationship (intensity of infection), and genetic variations between
parasite strains resulting in poor drug susceptibility and tolerance. (Savioli et al., 2004)
However, a growing understanding of modifiable host factors affecting treatment efficacy is
needed to guide control objectives and novel strategies. Nutritional status and dietary intake
have a great potential for altering drug metabolism and disposition—a tremendously important
clinical implication. Our results showed that the efficacy of single-dose oral albendazole for
curing hookworm infection was reduced for children with lower dietary diversity and protein
intake on treatment day. To our knowledge, our findings are the first to address host nutritional
status and dietary factors potentially affecting treatment efficacy, as measured by cure rate and
egg reduction rate.
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Dietary diversity is a powerful source of better nutrition and thus improved health
outcomes. There is an urgent need to explore ways to improve individual nutritional status
through dietary diversity as nutritional deficiencies and low dietary protein intake may delay
normal worm expulsion and perpetuate reinfection. Modifiable host factors may play an
important role for maximizing efficacy of existing drug compounds and improving treatment
response. Single-dose administration of albendazole cured infection and reduced intensity of
infection with differing levels of efficacy across the study population—a promising hypothesis is
the influential role of host nutritional status and dietary factors in affecting response to
albendazole as seen in the present study. The results show that the anthelminthic treatment was
much less effective in subjects with lower dietary diversity and protein intake. By evaluating
response to albendazole treatment among hookworm infected participants and identifying
modifiable host factors affecting resultant efficacy (as defined by egg reduction rate), we were
able to highlight potential biological, chemical, and physical factors important for the correction
and optimization of future helminth control.

77

References

Scholarly Journal Articles
Albonico, M. (2003). "Methods to sustain drug efficacy in helminth control programmes." Acta
Trop 86(2-3): 233-242.
Albonico, M., D. Engels, et al. (2004). "Monitoring drug efficacy and early detection of drug
resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth
control." Int J Parasitol 34(11): 1205-1210.
Anantaphruti, M. T., S. Nuamtanong, et al. (2007). “Responses to albendazole treatment for
hookworm infection in ethnic Thai and immigrant in west-central Thailand.” Journal of Health
Science 53(4): 443-449.
Anthony, L. E. (1973). "Effects of protein-calorie malnutrition on drug metabolism in rat liver
microsomes." J Nutr 103(6): 811-820.
Arimond, M. and M. T. Ruel. (2004). “Dietary diversity is associated with child nutritional
status: evidence from 11 demographic and health surveys.” J Nutr 134(10): 2579-2585.
Bidlack, W. R., R. C. Brown, et al. (1986). "Nutritional parameters that alter hepatic drug
metabolism, conjugation, and toxicity." Fed Proc 45(2): 142-148.
Bolin, T. D., A. E. Davis, et al. (1977). "Effect of iron and protein deficiency on the expulsion of
Nippostrongylus brasiliensis from the small intestine of the rat." Gut 18(3): 182-186.
Brooker, S., J. Bethony, et al. (2004). "Human hookworm infection in the 21st century." Adv
Parasitol 58: 197-288.
Brooker, S., A. Jardim-Botelho, et al. (2007). "Age-related changes in hookworm infection,
anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in
south-eastern Brazil." Trans R Soc Trop Med Hyg 101(2): 146-154.
Campbell, W. C. (1990). “Benzimidazoles: veterinary uses.” Parasitology Today 6(4): 130-133.
Coles, G. C., J. M. East, et al. (1975). “The mechanism of action of the anthelmintic levamisole.”
Gen Pharmac 6: 309-313.
Cook, G. C. (1990). “Use of benzimidazole chemotherapy in human helminthiases: indications
and efficacy” Parasitology Today 6(4): 133-136.
Danquah, I., E. Dietz, et al. (2009). "Reduced efficacy of intermittent preventive treatment of
malaria in malnourished children." Antimicrob Agents Chemother 53(5): 1753-1759.

78

Dreyfuss, M. L., R. J. Stoltzfus, et al. (2000). "Hookworms, malaria and vitamin A deficiency
contribute to anemia and iron deficiency among pregnant women in the plains of Nepal." J Nutr
130(10): 2527-2536.
Duncombe, V. M., T. D. Bolin, et al. (1977). "Nippostrongylus brasiliensis infection in the rat:
effect of iron and protein deficiency and dexamethasone on the efficacy of benzimidazole
anthelmintics." Gut 18: 892-896.
Duncombe, V. M., T. D. Bolin, et al. (1979). "Nippostrongylus brasiliensis infection in the rat:
effect of iron and protein deficiency on the anthelmintic efficacy of mebendazole, pyrantel,
piperazine, and levamisole." Gut 20(4): 305-308.
Duncombe, V. M., T. D. Bolin, et al. (1977). “The effect of iron and protein deficiency on the
efficacy of anthelmintic therapy.” Proc Nutr Soc Aust 2(73).
Homeida, M., Z. A. Karrar, et al. (1979). “Drug metabolism in undernourished children: a study
with antipyrine.” Arch Dis Child 54: 299-302.
Horton, J. (2000). "Albendazole: a review of anthelmintic efficacy and safety in humans."
Parasitology 121 Suppl: S113-132.
Hotez, P. J., J. Bethony, et al. (2005). "Hookworm: "the great infection of mankind"." PLoS Med
2(3): e67.
Hotez, P. J., S. Brooker, et al. (2004). "Hookworm infection." N Engl J Med 351(8): 799-807.
Humphries, D., E. Mosites, et al. (2011). "Epidemiology of hookworm infection in Kintampo
North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment
failure." Am J Trop Med Hyg 84(5): 792-800.
Jarrett, E. E. E. (1976). “IgE production in infections with helminth parasites.” Current Titles in
Immunology, Transplantation 4: 529.
Jongsuksuntigul, P., C. Jeradit, et al. (1993). “A comparative study on the efficacy of
albendazole and mebendazole in the treatment of ascariasis, hookworm infection and
trichuriasis.” The Southeast Asian Journal of Tropical Medicine and Public Health 24(4): 724729.
Katz, N., A. Chaves, et al. (1972). “A simple device for quantitative stool thick smear technique
in schistosomiasis mansoni.” Rev Inst Med Trop S Paulo 14: 394-400.
Keiser, J. and J. Utzinger (2008). "Efficacy of current drugs against soil-transmitted helminth
infections: systematic review and meta-analysis." JAMA 299(16): 1937-1948.

79

Knopp, S., K. A. Mohammed, et al. (2010). "Albendazole and mebendazole administered alone
or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial."
Clin Infect Dis 51(12): 1420-1428.
Kohri, N., Y. Yamayoshi, et al. (2010). “Improving the oral bioavailability of albendazole in
rabbits by the solid dispersion technique.” Journal of Pharmacy and Pharmacology 51(2): 159164.
Koski, K. G. and M. E. Scott (2001). "Gastrointestinal nematodes, nutrition and immunity:
breaking the negative spiral." Annu Rev Nutr 21: 297-321.
Krishnaswamy, K. (1978). "Drug metabolism and pharmacokinetics in malutrition." Clin
Pharmacokinet 3(3): 216-240.
Lacey, E. (1990). “Mode of action of benzimidazoles.” Parasitology Today 6(4): 112-115.
Lange, H., R. Eggers, et al. (1988). "Increased systemic availability of albendazole when taken
with a fatty meal." Eur J Clin Pharmacol 34(3): 315-317.
Loukas, A. and P. Prociv (2001). "Immune responses in hookworm infections." Clin Microbiol
Rev 14(4): 689-703, table of contents.
Mao, Z. L., Y. K. Tam, et al. (2006). "Effect of protein and calorie malnutrition on drug
metabolism in rat - in vitro." J Pharm Pharm Sci 9(1): 60-70.
McKellar, Q. A. and E. W. Scott (1990). "The benzimidazole anthelmintic agents--a review." J
Vet Pharmacol Ther 13(3): 223-247.
Mei, Z., M. E. Coqswell, et al. (2005). “Hemoglobin and ferritin are currently the most efficient
indicators of population response to iron interventions: an analysis of nine randomized controlled
trials.” J Nutr 135(8): 1974-1980.
Miller, M. J., I. M. Krupp, et al. (1974). “Mebendazole.” JAMA 230(10): 1412-1414.
Munst, G. J., G. Karlaganis, et al. (1980). “Plasma concentrations of mebendazole during
treatment of echinococcosis.” Eur J Clin Pharmacol 17: 375-378.
Nagy, J., H. G. Schipper, et al. (2002). “Effect of grapefruit juice or cimetidine coadministration
on albendazole bioavailability.” Amer J Med Hyg 66: 260–263.
Prichard, R. K. (2007). “Markers for benzimidazole resistance in human parasitic nematodes?”
Parasitology 134: 1087-1092.
Saathoff, E., A. Olsen, et al. (2005). "Ecologic covariates of hookworm infection and reinfection
in rural Kwazulu-natal/south Africa: a geographic information system-based study." Am J Trop
Med Hyg 72(4): 384-391.

80

Sanchez, S. F., L. I. Alvarez, et al. (1997). "Fasting-induced changes to the pharmacokinetic
behaviour of albendazole and its metabolites in calves." J Vet Pharmacol Ther 20(1): 38-47.
Santos, C. A. and J. I. Boullata (2005). "An approach to evaluating drug-nutrient interactions."
Pharmacotherapy 25(12): 1789-1800.
Savioli, L., M. Albonico, et al. (2004). "Progress in the prevention and control of schistosomiasis
and soil-transmitted helminthiasis." Parasitol Int 53(2): 103-113.
Soukhathammavong, P. A., S. Sayasone, et al. (2012). "Low efficacy of single-dose albendazole
and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR."
PLoS Negl Trop Dis 6(1): e1417.
Steinmann, P., J. Utzinger, et al. (2011). "Efficacy of single-dose and triple-dose albendazole and
mebendazole against soil-transmitted helminths and Taenia spp.: a randomized controlled trial."
PLoS One 6(9): e25003.
Stoltzfuz, R. J., M. Albonico, et al. (1998). “Effects of the Zanzibar school-based deworming
program on iron status of children.” American Journal of Clinical Nutrition 68: 179-186.
Theorides, V. J., R. J. Gyurik, et al. (1975). “Anthelminthic activity of albendazole against liver
flukes, tapeworms, lung and gastrointestinal roundworms.” Experientia 15: 702-703.
Theorides, V. J., R. J. Gyurik, et al. (1975). ”Anthelmintic activity of albendazole against liver
flukes, tapeworms, lung and gastrointestinal roundworms. Experientia 15: 702-703.
Vercruysse, J., J. M. Behnke, et al. (2011). "Assessment of the anthelmintic efficacy of
albendazole in school children in seven countries where soil-transmitted helminths are endemic."
PLoS Negl Trop Dis 5(3): e948.
Vercruysse, J., M. Albonico, et al. (2011). “Is anthelmintic resistance a concern for the control of
human soil-transmitted helminths?” International Journal for Parasitology: Drugs and Drug
Resistance 1: 14-27.
Wright, V. and Q. Bickle (2005). "Immune responses following experimental human hookworm
infection." Clin Exp Immunol 142(2): 398-403.
Zeim, J. B., A. Olsen, et al. (2006). “Distribution and clustering of Oesophagostomum bifurcum
and hookworm infections in northern Ghana.” Parasitology 132(4): 525-534.

81

Other Sources
Gillespie, S. H. (2001). “Intestinal nematodes.” Principles and Practice of Clinical Parasitology
21: 561-583.
Hotez, P. J. (2006). “Hookworm infections.” Tropical Infectious Diseases: Principles, Pathogens,
and Practice 116: 799-804.
Montresor, A., D. W. T. Crompton, et al. “Guidelines for the evaluation of soil-transmitted
helminthiases and schistosomiasis at community level.” WHO.
WHO. (2009). “WHO child growth standards and the identification of severe acute malnutrition
in infants and children.”
WHO. (2008). “Worldwide prevalence of anaemia 1993-2005.”

82

